Affordable Access

Publisher Website

Exploiting innovation options: an empirical analysis of R& D-intensive firms

Authors
Journal
Journal of Economic Behavior & Organization
0167-2681
Publisher
Elsevier
Publication Date
Volume
35
Issue
2
Identifiers
DOI: 10.1016/s0167-2681(98)00055-9
Keywords
  • Technological Innovations
  • Innovation Options
  • Biotechnology
Disciplines
  • Pharmacology

Abstract

Abstract This paper examines the mechanisms adopted by R&D-intensive firms to appropriate value from research capabilities. New technical opportunities, innovation options, can be exploited through internal development or through their exchange in intermediate knowledge markets. An analysis of biopharmaceutical research projects demonstrates that transaction cost hazards manifest themselves in both the internal and market-mediated alternatives. The impact of information asymmetry conditions is found to be contingent on firm capabilities; firms with high levels of development-related resources demonstrate a negative relationship between information asymmetry conditions and reliance on market exchange, while firms with low levels of such resources demonstrate a positive relationship.

There are no comments yet on this publication. Be the first to share your thoughts.